Introduction: Who Should Undergo Diagnostics
Diagnosing stage 4 kidney cancer often begins with discovering signs that cancer has already spread beyond the kidney. Many people discover they have kidney cancer by accident when doctors are looking for something else entirely. Around half of kidney tumors are found during imaging tests like CT scans or X-rays performed for unrelated reasons, such as checking for a kidney stone or investigating abdominal pain.[4]
If you experience certain symptoms, your doctor will likely recommend diagnostic testing. These warning signs can include blood in your urine, a lump or mass in your abdomen, persistent pain in your side or back, unexplained weight loss, tiredness that won’t go away, or fever that comes and goes without explanation.[1] However, it’s important to understand that kidney cancer can be quite sneaky—it often doesn’t show up in routine urine or blood tests, which is why many cases are caught late or accidentally.[8]
Once a kidney tumor has been found, additional testing is necessary to determine whether the cancer is stage 4. At this stage, the disease may have grown outside the protective tissue around the kidney, spread to the adrenal gland sitting on top of the kidney, reached nearby or distant lymph nodes, or traveled to other organs such as the lungs, bones, brain, or liver.[5] Knowing exactly where and how far the cancer has spread helps your medical team create the most appropriate treatment plan for your situation.
If you’ve been diagnosed with an earlier stage of kidney cancer and have completed treatment, regular follow-up testing remains essential. Cancer can return or spread even after successful initial treatment, so ongoing monitoring helps catch any changes early.[20]
Classic Diagnostic Methods for Stage 4 Kidney Cancer
When doctors suspect kidney cancer or need to determine how far it has spread, they use a combination of different tests. Each test provides specific information that helps build a complete picture of your health and the cancer’s behavior.
Physical Examination and Medical History
Your doctor will begin with a thorough physical exam to check your overall health. This includes measuring your vital signs like blood pressure, temperature, weight, and pulse. They will also check for any lumps or masses in your abdomen and look for signs of swelling or other physical changes.[4] Your medical team will ask detailed questions about your symptoms, any medicines you take, other health conditions you have, and whether anyone in your family has had kidney cancer or related diseases. This information helps doctors understand your risk factors and guides their testing decisions.
Blood Tests
Although blood tests cannot directly detect kidney cancer, they provide valuable information about how well your kidneys are working and your general health status. A complete blood count (CBC) measures different types of cells in your blood, including red blood cells, white blood cells, and platelets. This test can show if you have anemia (low red blood cell count) or other blood-related problems.[4]
Blood chemistry tests check how well your liver and kidneys are functioning and measure important substances called electrolytes, such as sodium and potassium, that help your body work properly. When kidney cancer reaches stage 4, these tests become especially important because they show how the disease is affecting your body’s ability to filter waste and maintain balance.
Urinalysis
Urinalysis is a test that examines your urine (pee) for blood, extra proteins, or signs of infection. Finding blood in your urine can be an important clue, though it doesn’t automatically mean you have cancer—many other conditions can cause this symptom as well.[4]
Computed Tomography (CT) Scan
A CT scan is one of the most important imaging tests for diagnosing and staging kidney cancer. This test uses X-rays taken from multiple angles to create detailed, three-dimensional images of the inside of your body. For kidney cancer, doctors typically scan your abdomen (belly) and pelvis to see your kidneys and the areas around them. This helps them determine if cancer has spread to nearby structures.[4]
Before your CT scan, you may be asked to drink a special liquid or receive an injection into your vein. This substance, called contrast, makes certain tissues show up more clearly in the images. If you’ve ever had a bad reaction to contrast material or iodine in the past, make sure to tell your doctor beforehand so they can take appropriate precautions.
A chest CT scan is also commonly performed to check whether kidney cancer has spread to the lungs, which is one of the common places where stage 4 kidney cancer travels.[4]
Magnetic Resonance Imaging (MRI)
An MRI uses powerful magnets and radio waves instead of X-rays to create detailed pictures of your body’s internal structures. This test is particularly useful for checking whether kidney cancer has spread to major blood vessels or to the brain, which are important considerations for stage 4 disease.[4]
During an MRI, you need to lie very still inside an enclosed space for anywhere from 15 to 90 minutes. The machine can feel tight and makes loud noises during the scan. If you feel anxious about being in small spaces, let your doctor know ahead of time—they may be able to offer medication or other options to help you feel more comfortable. Also inform your medical team if you have any metal in your body, such as a hip replacement or pacemaker, as these can interfere with the magnetic field.
Chest X-Ray
A simple chest X-ray can show whether cancer has spread to your lungs. If something suspicious appears on the X-ray, your doctor will likely order a CT scan of your chest for a more detailed look.[4] The lungs are one of the most common sites where kidney cancer spreads, so checking them is a standard part of diagnosing stage 4 disease.
Bone Scan
If doctors suspect that kidney cancer may have spread to your bones, they may order a bone scan. Before this imaging test, a small amount of radioactive material is injected into a vein. Over the next few hours, this material travels through your bloodstream and collects in areas where bone is damaged or growing abnormally. A special camera then takes pictures that show whether cancer has reached your bones.[4]
Biopsy
A biopsy is a procedure where a doctor removes a small sample of tissue to examine under a microscope. For kidney cancer, a biopsy isn’t always necessary because imaging tests often provide enough information. However, in certain situations, your doctor may recommend one to confirm the diagnosis or determine the exact type of cancer cells present.[4]
During a kidney biopsy, a thin needle is carefully inserted through your skin into the kidney mass, usually guided by ultrasound or CT imaging. The tissue sample is then sent to a laboratory where a specialist called a pathologist examines it to identify cancer cells and determine what kind of kidney cancer you have. This information can be crucial for selecting the most effective treatment.
Staging the Cancer
Once all the diagnostic tests are completed, doctors use the information to assign a stage to your cancer. Stage 4 renal cell cancer means one of the following: the tumor has grown outside the protective layer of tissue around the kidney or into the adrenal gland; the cancer has spread to nearby lymph nodes; or the cancer has spread to distant parts of the body such as the lungs, bones, liver, or brain.[5]
Understanding the stage helps your healthcare team predict how the disease might progress and decide which treatments are most likely to help. In stage 4 kidney cancer, the cancer has clearly moved beyond the point where surgery alone can cure it, so treatment typically focuses on controlling the disease, relieving symptoms, and maintaining quality of life as much as possible.[3]
Diagnostics for Clinical Trial Qualification
Clinical trials are research studies that test new treatments or combinations of treatments to see if they work better than current options. If you have stage 4 kidney cancer, your doctor might suggest enrolling in a clinical trial. To participate, you’ll need to undergo specific diagnostic tests that help researchers determine whether you’re eligible for the study.
The exact tests required depend on the particular clinical trial and what it’s studying. However, there are some standard evaluations that most trials use to qualify patients. These typically include many of the same tests used for initial diagnosis—blood tests, imaging scans, and assessments of your overall health and kidney function.[4]
For trials testing new treatments for stage 4 kidney cancer, researchers need to know specific details about your disease. This includes the exact type of kidney cancer you have (such as clear cell, papillary, or chromophobe), how far it has spread, which organs are affected, and how well your remaining kidney is working. Blood tests that measure your kidney function, liver function, and blood cell counts are particularly important because they show whether your body can safely handle the treatment being studied.
Many clinical trials for kidney cancer also consider classification systems that predict how patients might respond to treatment. One widely used system is the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) classification. This system looks at factors like your calcium levels, hemoglobin (the protein in red blood cells that carries oxygen), white blood cell count, platelet count, and how well you can perform daily activities. These factors help researchers group patients by risk level and match them with appropriate trials.[3]
Imaging tests remain crucial for clinical trial screening. Researchers need baseline scans—pictures taken before treatment begins—so they can later compare new images and measure whether the treatment is shrinking tumors or slowing cancer growth. CT scans, MRIs, and sometimes PET scans create this baseline record. During the trial, you’ll undergo repeat imaging at scheduled intervals to track how your cancer responds to the experimental treatment.
Some trials have very specific requirements about previous treatments. They may only accept patients who haven’t received certain types of therapy yet, or conversely, they might specifically enroll people whose cancer no longer responds to standard treatments. Your diagnostic records showing what treatments you’ve tried and how your cancer responded help determine which trials might be right for you.
Your healthcare team can help you find clinical trials that match your situation and explain the diagnostic testing involved in qualifying for them. Organizations like the Kidney Cancer Association and major cancer centers maintain databases of active trials that you and your doctor can search together.[13]



